ArticleJournal, genetic engineering & biotechnology2025
Integrative analysis of transcriptomics and drug-target networks identifies SMN1 as a novel biomarker and therapeutic target for amyotrophic lateral sclerosis.
Deboral Eshak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.